Meeting
2021 Gastrointestinal Cancers Symposium
Survival outcomes in the modern era for localized pancreatic cancer with multi-agent chemotherapy and stereotactic body radiation therapy.
Authors
Shuchi Sehgal
Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Shuchi Sehgal , Colin Hill , Wei Fu , Chen Hu , Amy Hacker-Prietz , Lei Zheng , Daniel A. Laheru , Joseph M. Herman , Amol Narang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Pancreatic Cancer
Track
Pancreatic Cancer
Sub Track
Other
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 444)
DOI
10.1200/JCO.2021.39.3_suppl.444
Abstract #
444
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Long-term outcomes with neoadjuvant chemotherapy with or without stereotactic body radiation therapy in patients with borderline resectable and locally advanced pancreatic adenocarcinoma.
First Author: Colin Hill
Poster
2021 Gastrointestinal Cancers Symposium
Long-term outcomes of a prospective single institution study with multiagent chemotherapy and stereotactic body radiation therapy in locally advanced or recurrent pancreatic adenocarcinoma.
First Author: Colin Hill
Poster
2018 ASCO Quality Care Symposium
Are real-world patient-reported outcomes associated with survival in patients with advanced pancreatic cancer?
First Author: Wei Fang Dai
Poster
2018 Gastrointestinal Cancers Symposium
Neoadjuvant therapy outcomes in nonmetastatic pancreatic cancer.
First Author: Jeanette Muniz Kovtun